GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain by Eijkelkamp, Niels, Heijnen, Cobi J, Willemen, Hanneke L. D. M, Deumens, Ronald, Joosten, Elbert A. J, Kleibeuker, Wendy, den Hartog, Ilona J. M, van Velthoven, Cindy T. J, Nijboer, Cora, Nassar, Mohammed A, Dorn, Gerald W., II, Wood, John N, Kavelaars, Annemieke

Get full text

Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours by Bate-Eya, Laurel T, Ebus, Marli E, Koster, Jan, den Hartog, Ilona J.M, Zwijnenburg, Danny A, Schild, Linda, van der Ploeg, Ida, Dolman, M. Emmy M, Caron, Huib N, Versteeg, Rogier, Molenaar, Jan J

Get full text

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma by Dolman, M Emmy M, Poon, Evon, Ebus, Marli E, den Hartog, Ilona J M, van Noesel, Carel J M, Jamin, Yann, Hallsworth, Albert, Robinson, Simon P, Petrie, Kevin, Sparidans, Rolf W, Kok, Robbert J, Versteeg, Rogier, Caron, Huib N, Chesler, Louis, Molenaar, Jan J

Get full text

Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth by Lamers, Fieke, Schild, Linda, den Hartog, Ilona J.M, Ebus, Marli E, Westerhout, Ellen M, Ora, Ingrid, Koster, Jan, Versteeg, Rogier, Caron, Huib N, Molenaar, Jan J

Get full text

High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition by Bate-Eya, Laurel T, den Hartog, Ilona J M, van der Ploeg, Ida, Schild, Linda, Koster, Jan, Santo, Evan E, Westerhout, Ellen M, Versteeg, Rogier, Caron, Huib N, Molenaar, Jan J, Dolman, M Emmy M

Get full text

Liquid chromatography–tandem mass spectrometric assay for the cyclin-dependent kinase inhibitor AT7519 in mouse plasma by Dolman, M. Emmy M., den Hartog, Ilona J.M., Molenaar, Jan J., Schellens, Jan H.M., Beijnen, Jos H., Sparidans, Rolf W.

Get full text

Liquid chromatography-tandem mass spectrometric assay for the light sensitive survivin suppressant sepantronium bromide (YM155) in mouse plasma by Dolman, M. Emmy M., den Hartog, Ilona J.M., Molenaar, Jan J., Schellens, Jan H.M., Beijnen, Jos H., Sparidans, Rolf W.

Get full text

Metabolomic profiling of microbial disease etiology in community-acquired pneumonia by den Hartog, Ilona, Zwep, Laura B, Vestjens, Stefan M. T, Harms, Amy C, Voorn, G. Paul, de Lange, Dylan W, Bos, Willem J. W, Hankemeier, Thomas, van de Garde, Ewoudt M. W, van Hasselt, J. G. Coen

Get full text

Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia by den Hartog, Ilona, Zwep, Laura B., Meulman, Jacqueline J., Hankemeier, Thomas, van de Garde, Ewoudt M. W., van Hasselt, J. G. Coen

Get full text

Differential metabolic host response to pathogens associated with community-acquired pneumonia by den Hartog, Ilona, Karu, Naama, Zwep, Laura B., Voorn, G. Paul, van de Garde, Ewoudt M.W., Hankemeier, Thomas, van Hasselt, J.G. Coen

Get full text

Abstract B09: MCL-1 inhibition improves ABT199 efficacy for BCL-2-dependent neuroblastoma by Bate-Eya, Laurel T., Hartog, Ilona J.M. den, Ploeg, Ida van der, Schild, Linda, Koster, Jan, Versteeg, Rogier, Caron, Huib N., Molenaar, Jan J., Dolman, M. Emmy M.

Get full text